Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Cryogenic Vials Market: By Material By Capacity, By End User and Region Forecast 2019-2030
Cryogenic Vials Market: By Material By Capacity, By End User and Region Forecast 2019-2030
Cryogenic Vials Market size was valued at US$ 320.1 million in 2023 and is poised to grow at a significant CAGR of 6.2% from 2024-2030. Cryogenic vials are used to store samples for lengthy periods of time and are thought to be the best and most leak-proof option. It's ideal for storing a variety of specimens as well as biological materials at extremely low temperatures. The vial's rapid thread design aids in both removal and tightening. They're usually packaged in tamper-proof, unique safety-lock bags. Industry trends in the market are evolving, which will aid players in developing successful long-term strategies.
Both established and emerging markets have implemented business growth techniques. COVID-19 is an unprecedented worldwide public health crisis that has impacted practically every business, and its long-term repercussions are expected to have an influence on industry growth during the projection period. Our continuous study is enhancing our research approach to guarantee that fundamental COVID-19 concerns and potential solutions are included. The research examines COVID-19 in light of changes in consumer behaviour and demand, purchasing patterns, supply chain re-routing, market dynamics, and government involvement. The market report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.
Study Period
2025-2031Base Year
2024CAGR
6.2%Largest Market
North-AmericaFastest Growing Market
Europe
The global cryogenic vials market is primarily driven by surge in demand for biobanking and growth in biotechnological industry. In addition, advancements in supply chain management lead to ease in the transport and storage of cryogenic products expected to fuel the global market over the forecast period. Furthermore, rise in R&D segment may positively impact the growth of market share. However, cryogenic vials does not allow the frequent confirmation testing and chances of contamination are expected to hamper the global market over the forecast period.
Geographically cryogenic vials market is divided into five key regions, i.e. North America, Asia Pacific, Europe, Latin America, and The Middle East and Africa.North America market is projected to grow at significant rates owing to the factors such as well established pharmaceutical and biotech sector and increase in the R&D activities related to the biotechnology that requires the cryogenic storage products. Furthermore, growing demand for cell banks expected to boost the North America market. Europe market is expected to have notable market growth rate owing to the presence of the major market players and advancements in biotechnological industry leading to the rise in the research and development activities. Asia Pacific market is expected to have promising growth opportunities owing to rapid development in Pharma and Biotechnological industries due to global expansion of the local and multinational players. In addition, increase in biotechnological research activities in the region due to low cost and rise in demand for the cell and biobanks are expected to boost the Asia Pacific market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2023 |
US$ 320.1 million |
|
Market CAGR |
6.2% |
|
By Material |
|
|
By Capacity |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The cryogenic vials market was valued at US$ 320.1 million in 2023 and is poised to grow at a significant CAGR of 6.2% by 2030.
Thermo Fisher Scientific Inc. (U.S.), Wheaton Holding Corporation (U.S.), Santa Cruz Biotechnology, Inc. (U.S.), BioCision, LLC (U.S.), Starlab International GmbH, Argos Technologies, Inc. (U.S.)
North-America is the fastest-growing in the market
| 1. Executive Summary |
| 2. Global Cryogenic Vials Market Introduction |
| 2.1.Global Cryogenic Vials Market - Taxonomy |
| 2.2.Global Cryogenic Vials Market - Definitions |
| 2.2.1.Material |
| 2.2.2.Capacity |
| 2.2.3.End Users |
| 2.2.4.Region |
| 3. Global Cryogenic Vials Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Cryogenic Vials Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Cryogenic Vials Market By Material, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Polyethylene |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Polypropylene |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Global Cryogenic Vials Market By Capacity, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. More than 5ml |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. 2-5ml |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Less than 2ml |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Cryogenic Vials Market By End Users, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Research Institute |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Healthcare organization |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Pharma / Biotechnological Manufacturer |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Cryogenic Vials Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Cryogenic Vials Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Material Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Polyethylene |
| 9.1.2.Polypropylene |
| 9.2. Capacity Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.More than 5ml |
| 9.2.2.2-5ml |
| 9.2.3.Less than 2ml |
| 9.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Research Institute |
| 9.3.2.Healthcare organization |
| 9.3.3.Pharma / Biotechnological Manufacturer |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Cryogenic Vials Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Material Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Polyethylene |
| 10.1.2.Polypropylene |
| 10.2. Capacity Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.More than 5ml |
| 10.2.2.2-5ml |
| 10.2.3.Less than 2ml |
| 10.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Research Institute |
| 10.3.2.Healthcare organization |
| 10.3.3.Pharma / Biotechnological Manufacturer |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Cryogenic Vials Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Material Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Polyethylene |
| 11.1.2.Polypropylene |
| 11.2. Capacity Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.More than 5ml |
| 11.2.2.2-5ml |
| 11.2.3.Less than 2ml |
| 11.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Research Institute |
| 11.3.2.Healthcare organization |
| 11.3.3.Pharma / Biotechnological Manufacturer |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Cryogenic Vials Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Material Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Polyethylene |
| 12.1.2.Polypropylene |
| 12.2. Capacity Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.More than 5ml |
| 12.2.2.2-5ml |
| 12.2.3.Less than 2ml |
| 12.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Research Institute |
| 12.3.2.Healthcare organization |
| 12.3.3.Pharma / Biotechnological Manufacturer |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Cryogenic Vials Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Material Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Polyethylene |
| 13.1.2.Polypropylene |
| 13.2. Capacity Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.More than 5ml |
| 13.2.2.2-5ml |
| 13.2.3.Less than 2ml |
| 13.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Research Institute |
| 13.3.2.Healthcare organization |
| 13.3.3.Pharma / Biotechnological Manufacturer |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Thermo Fisher Scientific Inc. (U.S.) |
| 14.2.2.Wheaton Holding Corporation (U.S.) |
| 14.2.3.Santa Cruz Biotechnology, Inc. (U.S.) |
| 14.2.4.BioCision, LLC (U.S.) |
| 14.2.5.Starlab International GmbH |
| 14.2.6.Argos Technologies, Inc. (U.S.) |
| 14.2.7.Sumitomo Bakelite Co., Ltd. (Japan) |
| 14.2.8.EZ BioResearch LLC (U.S.) |
| 14.2.9.CELLTREAT Scientific Products (U.S.) |
| 14.2.10.MicroAnalytix AU. (Australia) |
| 14.2.11.Globe Scientific Inc. (U.S.) |
| 14.2.12.SiO2 Medical Products, Inc. (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.